Swiss drugmaker Novartis AG is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co for about US$7 billion, the Wall Street Journal reported on Saturday.
Novartis nears deal to buy US biotech firm Medicines Co for about US$7 billion: WSJ
